{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:27:08Z","timestamp":1783477628708,"version":"3.55.0"},"reference-count":17,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Path"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1136\/mp.52.3.135","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T19:10:34Z","timestamp":1230750634000},"page":"135-139","source":"Crossref","is-referenced-by-count":3,"title":["Absence of prolactin gene expression in colorectal cancer."],"prefix":"10.1136","volume":"52","author":[{"given":"A J","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K R","family":"Baumforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K W","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J G","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A G","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Plessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1999,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/1097-0142(19900501)65:9<2028::AID-CNCR2820650924>3.0.CO;2-9","article-title":"Plasma prolactin as an indicator of disease progression in advanced breast cancer","volume":"65","author":"Bhatavdekar, J.M.; Shah, N.G.; Balar, D.B.","year":"1990","unstructured":"Bhatavdekar JM, Shah NG, Balar DB, et al. Plasma prolactin as an indicator of disease progression in advanced breast cancer. Cancer 1990;65:2028\u201332.","journal-title":"Cancer"},{"key":"ref_2","first-page":"199","article-title":"Prolactin in advanced breast cancer. An Indian experience","volume":"3","author":"Bhatavdekar, J.M.; Giri, D.D.; Shah, N.G.","year":"1990","unstructured":"Bhatavdekar JM, Giri DD, Shah NG, et al. Prolactin in advanced breast cancer. An Indian experience. Breast Diseases 1990;3:199\u2013204.","journal-title":"Breast Diseases"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/bjc.1992.395","article-title":"Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of the colon and rectum","volume":"66","author":"Bhatavdekar, J.M.; Patel, D.D.; Giri, D.D.","year":"1992","unstructured":"Bhatavdekar JM, Patel DD, Giri DD, et al. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of the colon and rectum. Br J Cancer 1992;66:977\u201380.","journal-title":"Br J Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/1097-0142(19940201)73:3<570::AID-CNCR2820730312>3.0.CO;2-I","article-title":"Plasma prolactin in patients with colorectal cancer","volume":"73","author":"Patel, D.D.; Bhatavdekar, J.M.; Ghosh, A.","year":"1994","unstructured":"Patel DD, Bhatavdekar JM, Ghosh A, et al. Plasma prolactin in patients with colorectal cancer. Cancer 1994;73:570\u20134.","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/BF02208671","article-title":"Plasma and tumour prolactin in colorectal cancer patients","volume":"40","author":"Ilan, Y.; Sibirsky, O.; Livini, A.","year":"1995","unstructured":"Ilan Y, Sibirsky O, Livini A, et al. Plasma and tumour prolactin in colorectal cancer patients. Dig Dis Sci 1995;40: 2010\u201315.","journal-title":"Dig Dis Sci"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/BF01815271","article-title":"Control of prolactin secretion","volume":"68","author":"Benker, G.; Jaspers, C.; Hausler, G.","year":"1990","unstructured":"Benker G, Jaspers C, Hausler G, et al. Control of prolactin secretion. Klin Wochenschr 1990;68:1157\u201367.","journal-title":"Klin Wochenschr"},{"key":"ref_7","article-title":"Clinical chemistry","author":"Marshall, W.J.","year":"1992","unstructured":"Marshall WJ. Clinical chemistry, 2nd ed. New York: Gower Medical Publishing, 1992.","edition":"2nd ed"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/bja\/72.3.280","article-title":"EVect of anaesthesia on the cytokine responses to abdominal surgery","volume":"72","author":"Crozier, T.A.; Muller, J.E.; Quittkat, D.","year":"1994","unstructured":"Crozier TA, Muller JE, Quittkat D, et al. EVect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth 1994;72:280\u20135.","journal-title":"Br J Anaesth"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/bja\/76.5.640","article-title":"Laparoscopic cholecystectomy: haemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position","volume":"76","author":"O\u2019Leary, E.; Hubbard, K.; Tormey, W.","year":"1996","unstructured":"O\u2019Leary E, Hubbard K, Tormey W, et al. Laparoscopic cholecystectomy: haemodynamic and neuroendocrine responses after pneumoperitoneum and changes in position. Br J Anaesth 1996;76:640\u20134.","journal-title":"Br J Anaesth"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1399-6576.1998.tb05375.x","article-title":"General anaesthesia for surgery can influence circulating melatonin during daylight hours","volume":"42","author":"Reber, A.; Huber, P.R.; Ummenhofer, W.","year":"1998","unstructured":"Reber A, Huber PR, Ummenhofer W, et al. General anaesthesia for surgery can influence circulating melatonin during daylight hours. Acta Anaesthesiol Scand 1998;42:1050\u2013 6.","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref_11","first-page":"399","article-title":"Reduced number of natural killer cells in patients with pathological hyperprolactinaemia. Clin Exp Immunol","volume":"64","author":"Gerli, R.; Rambotti, P.; Nicoletti, I.","year":"1986","unstructured":"Gerli R, Rambotti P, Nicoletti I, et al. Reduced number of natural killer cells in patients with pathological hyperprolactinaemia. Clin Exp Immunol 1986;64:399\u2013406."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF00918091","article-title":"Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more eYcient","volume":"12","author":"Vidaller, A.; Guadarrama, F.; Llorente, L.","year":"1992","unstructured":"Vidaller A, Guadarrama F, Llorente L, et al. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more eYcient. J Clin Immunol 1992;12:210\u201315.","journal-title":"J Clin Immunol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0162-3109(89)90067-2","article-title":"Natural killer activity in hyperprolactinemic patients","volume":"18","author":"Matera, L.; Ciccarelli, E.; Cesano, A.","year":"1989","unstructured":"Matera L, Ciccarelli E, Cesano A, et al. Natural killer activity in hyperprolactinemic patients. Immunopharmacology 1989;18:143\u20136.","journal-title":"Immunopharmacology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0192-0561(96)00059-8","article-title":"Role of prolactin in the modulation of NK and LAK cell activity after shortor long-term morphine administration in neoplastic patients","volume":"10","author":"Provinciali, M.; Di Stefano, G.; Stronati, S.","year":"1996","unstructured":"Provinciali M, Di Stefano G, Stronati S, et al. Role of prolactin in the modulation of NK and LAK cell activity after shortor long-term morphine administration in neoplastic patients. Int J Immunopharmacol 1996;10:577\u201386.","journal-title":"Int J Immunopharmacol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0960-5428(96)00019-8","article-title":"Prolactin increases the susceptibility of primary leukemia cells to NK and LAK eVectors","volume":"6","author":"Oberholtzer, E.; Contarini, M.; Veglia, F.","year":"1996","unstructured":"Oberholtzer E, Contarini M, Veglia F, et al. Prolactin increases the susceptibility of primary leukemia cells to NK and LAK eVectors. Adv Neuroimmunol 1996;6:233\u201347.","journal-title":"Adv Neuroimmunol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0215(19960328)66:1<65::AID-IJC12>3.0.CO;2-A","article-title":"Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging","volume":"66","author":"Chakraborty, A.; Chakraborty, N.G.; Chattopadhyay, U.","year":"1996","unstructured":"Chakraborty A, Chakraborty NG, Chattopadhyay U. Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging. Int J Cancer 1996;66:65\u20139.","journal-title":"Int J Cancer"},{"key":"ref_17","first-page":"431","article-title":"Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract","volume":"268","author":"Nagano, M.; Chastre, E.; Choquet, A.","year":"1995","unstructured":"Nagano M, Chastre E, Choquet A, et al. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract. Am J Physiol 1995;268:G431\u201342.","journal-title":"Am J Physiol"}],"container-title":["Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/mp.52.3.135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:12:54Z","timestamp":1756055574000},"score":1,"resource":{"primary":{"URL":"https:\/\/mp.bmj.com\/lookup\/doi\/10.1136\/mp.52.3.135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,6,1]]},"published-print":{"date-parts":[[1999,6]]}},"alternative-id":["10.1136\/mp.52.3.135"],"URL":"https:\/\/doi.org\/10.1136\/mp.52.3.135","relation":{},"ISSN":["1366-8714","1472-4154"],"issn-type":[{"value":"1366-8714","type":"print"},{"value":"1472-4154","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]}}}